ANLVSGTBP• 3 Months (Normalized)
ANL vs GTBP (Adlai Nortye Group Ltd. vs GT Biopharma Inc.)
Showing Closing Date Range from Jul 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANL Performance $15.83
+49.34%
Adlai Nortye Group Ltd.
Normalized Baseline0.00%
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANL LEADS
+49.34 pts
ANL outperforming by 49.34 percentage points
ANLGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANL GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(60 dates)
| Date | ANL Price | ANL Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $15.83 | +49.34% | $- | - | |
| Sep 23, 2026 | $15.75 | +48.58% | $7.10 | +1337.25% | -1288.67% |
| Sep 22, 2026 | $16.60 | +56.60% | $- | - | |
| Sep 21, 2026 | $15.57 | +46.89% | $7.18 | +1353.44% | -1306.55% |
| Sep 18, 2026 | $15.74 | +48.49% | $7.16 | +1349.39% | -1300.90% |
| Sep 17, 2026 | $15.28 | +44.15% | $7.49 | +1416.19% | -1372.04% |
| Sep 16, 2026 | $15.52 | +46.42% | $7.81 | +1480.97% | -1434.55% |
| Sep 15, 2026 | $15.00 | +41.51% | $9.00 | +1721.86% | -1680.35% |
| Sep 14, 2026 | $15.93 | +50.28% | $11.63 | +2254.25% | -2203.97% |
| Sep 11, 2026 | $15.21 | +43.49% | $8.61 | +1642.91% | -1599.42% |
| Sep 10, 2026 | $15.09 | +42.36% | $6.18 | +1151.01% | -1108.65% |
| Sep 09, 2026 | $14.70 | +38.63% | $5.98 | +1110.53% | -1071.90% |
| Sep 08, 2026 | $15.51 | +46.32% | $- | - | |
| Sep 04, 2026 | $15.01 | +41.60% | $0.24 | -51.21% | +92.81% |
| Sep 03, 2026 | $14.75 | +39.15% | $0.25 | -48.99% | +88.14% |
Page 1 of 4